141080.KS · 리가켐바이오
South Korea · RS rating 2 · As of 2026-10-14
| Price | 66,200.00 KRW |
|---|---|
| 1-day change | +1.9% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 4 / 3 / 10 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 16 / 14 / 12 |
| Industry group (rank) | Medical-Biomed/Biotech (95) |
| EPS growth Q/Q | -88.9% |
| Sales growth Q/Q | -84.6% |
| Distance from 52-week high | +69.0% |
| Market cap (USD) | $2.0B |